Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

HDM1002

HDM1002 Tablets in Chinese Overweight and Obese Adult Subjects

Huadong Medicine · Phase 1 · Status n/r · Enrollment 72

NCT06520540

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
HDM1002 100 mgn/rn/rn/rn/r
HDM1002 200 mgn/rn/rn/rn/r
HDM1002 400 mgn/rn/rn/rn/r
Placebon/rn/rn/rn/r

Not shown

  • HDM1002 100 mg: endpoint not reported
  • HDM1002 200 mg: endpoint not reported
  • HDM1002 400 mg: endpoint not reported
  • Placebo: endpoint not reported